Busulfan-fludarabine as myeloablative conditioning regimen in allogeneic stem cell transplantation: incidence of complications and outcome. A single-centre experience

被引：0
|
作者：
Parma, M. [1 ]
Pioltelli, P. [1 ]
Terruzzi, E. [1 ]
Bozzani, S. [1 ]
Pogliani, E. [1 ]
机构：
[1] Osped San Gerardo, Monza, Italy
来源：
BONE MARROW TRANSPLANTATION | 2012年 / 47卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S94 / S94
页数：1
相关论文
共 50 条
  • [1] Myeloablative treosulfan as preparative regimen for allogeneic haematopoietic stem cell transplantation: a single-centre experience
    Trenschel, R
    Ditschkowski, M
    Elmaagacli, A
    Steckel, N
    Hlinka, M
    Peceny, R
    Ottinger, H
    Koldehoff, M
    Biersack, H
    Beelen, DW
    BONE MARROW TRANSPLANTATION, 2004, 33 : S33 - S34
  • [2] Myeloablative treosulfan as preparative regimen for allogeneic haematopoietic stem cell transplantation: a single-centre experience
    Trenschel, R
    Ditschkowski, M
    Elmaagacli, A
    Steckel, N
    Hlinka, M
    Peceny, R
    Ottinger, H
    Koldehoff, M
    Biersack, H
    Beelen, D
    BONE MARROW TRANSPLANTATION, 2005, 35 : S217 - S218
  • [3] New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2
    Sohn, S. K.
    Chae, Y. S.
    Kim, J. G.
    Cho, Y. Y.
    Moon, J. H.
    Shin, H. J.
    Chung, J. S.
    Cho, G. J.
    Yang, D. H.
    Lee, J. J.
    Kim, Y. K.
    Kim, H. J.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S203 - S204
  • [4] New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2
    Chae, Y. S.
    Sohn, S. K.
    Kim, J. G.
    Cho, Y. Y.
    Moon, J. H.
    Shin, H. J.
    Chung, J. S.
    Cho, G. J.
    Yang, D. H.
    Lee, J-J
    Kim, Y-K
    Kim, H-J
    BONE MARROW TRANSPLANTATION, 2007, 40 (06) : 541 - 547
  • [5] New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2
    Y S Chae
    S K Sohn
    J G Kim
    Y Y Cho
    J H Moon
    H J Shin
    J S Chung
    G J Cho
    D H Yang
    J-J Lee
    Y-K Kim
    H-J Kim
    Bone Marrow Transplantation, 2007, 40 : 541 - 547
  • [6] Myeloablative treosulfan as preparative regimen for allogeneic haematopoietic stem cell transplantation: A single-centre experience.
    Trenschel, R
    Ditschkowski, M
    Elmaagacli, A
    Steckel, NK
    Hlinka, M
    Peceny, R
    Ottinger, H
    Koldehoff, M
    Biersack, H
    Flasshove, M
    Beelen, DW
    BLOOD, 2004, 104 (11) : 914A - 914A
  • [7] Reduced-toxicity conditioning with fludarabine and busulfan prior to allogeneic stem cell transplantation in multiple myeloma patients. A single-centre experience
    Grassi, A.
    Mico, C. M.
    Algarotti, A.
    Oldani, E.
    Rambaldi, A.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S427 - S427
  • [8] Fludarabine and busulfan (FluBu regimen) as myeloablative conditioning regimen for allogeneic PBSCT in 71 leukaemic patients (a single centre study)
    Iravani, M
    Tavakoli, M
    Shamshiri, AR
    Evazi, MR
    Mousavi, A
    Bahar, B
    Ghavamzadeh, A
    BONE MARROW TRANSPLANTATION, 2005, 35 : S218 - S219
  • [9] Efficacy of treosulfan in combination with fludarabine as conditioning regimen in allogeneic transplantation as compared with a myeloablative conditioning using busulfan and fludarabine
    Calvo Sanchez, J. A.
    Fernandez Garcia, S.
    Aranguren del Castillo, L.
    Fernandez-Luis, S.
    Yanez San Segundo, L.
    Insunza Gaminde, A.
    Fernandez Escalada, N.
    Martin Sanchez, G.
    Colorado Araujo, M. M.
    Lopez Duarte, M.
    Sanchez Escamilla, M.
    Montes Gaisan, C.
    Romon Alonso, J. I.
    Arroyo Rodriguez, J. L.
    Ocio San Miguel, E. M.
    Bermudez Rodriguez, M. A.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 166 - 167
  • [10] Busulfan and Fludarabine As Conditioning Regimen for Unrelated Allogeneic Stem Cell Transplant: A Single-Center Experience
    Sutamtewagul, Grerk
    Abbi, Kamal Kant Singh
    Farooq, Umar
    Mott, Sarah L.
    Dozeman, Lindsay
    Silverman, Margarida
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S358 - S358
12345